Sandra Steensels, Jixuan Qiao, Yanzhen Zhang, Kristal M. Maner‐Smith, Nourhan Kika, Corey D. Holman, Kathleen E. Corey, W. Clay Bracken, Eric A. Ortlund, Baran A. Ersoy – 4 June 2020
Meghan E. Sise, Ian Strohbehn, Donald Chute, Kathleen E. Corey, Dahlene N. Fusco, Venkata S Sabbisetti, Sushrut S. Waikar, Raymond T. Chung – 4 June 2020 – Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD).
John M. Vierling, Nanda Kerkar, Albert J. Czaja, Cara L. Mack, David Adams, David N. Assis, Michael P. Manns, Marlyn J. Mayo, Tarek Nayfeh, Abdul Mounaem M. Majzoub, Muayad A. Alzuabi, Jingyi Ding, Samir Haffar, M. Hassan Murad, Mouaz Alsawas – 4 June 2020
Karan Kumar, Anand Kulkarni – 3 June 2020
Keyur Patel, Chuhan Chung, Robert P. Myers – 3 June 2020
Dimitrios Patoulias, Alexandra Katsimardou, Christodoulos Papadopoulos, Michael Doumas – 3 June 2020
Ani Kardashian, Jin Ge, Charles E. McCulloch, Matthew R. Kappus, Michael A. Dunn, Andres Duarte‐Rojo, Michael L. Volk, Robert S. Rahimi, Elizabeth C. Verna, Daniel R. Ganger, Daniela Ladner, Jennifer L. Dodge, Brian Boyarsky, Mara McAdams‐DeMarco, Dorry L. Segev, Jennifer C. Lai – 3 June 2020
Xin Wang, Ling‐yue Dong, Qu‐jing Gai, Wei‐lun Ai, Yuan Wu, Wei‐chun Xiao, Jing Zhang, Wei An – 2 June 2020 – It is well known that excessive cholesterol accumulation within hepatocytes deteriorates nonalcoholic fatty liver disease (NAFLD). Augmenter of liver regeneration (ALR) has been reported to alleviate NAFLD through anti‐apoptosis; however, whether ALR could protect liver from cholesterol‐induced NAFLD remains unclear.
Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Sezai Yilmaz – 2 June 2020
Sanjay Kumar Yadav, Narendr Singh Choudhary, Arvinder Singh Soin – 2 June 2020